Latest gabapentin Stories
NEWARK, Calif., Jan. 29, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) announced today a favorable "Markman" claim construction ruling by Judge Joel A.
A new neuroscience study sheds light on the biological underpinnings of obesity.
Gabapentin is a gamma-aminobutyric acid derivative, and was approved for the treatment of neuropathic pain by the U.S. Food and Drug Administration in 2002.
- A woman chauffeur.
- A woman who operates an automobile.